[Federal Register: October 6, 1999 (Volume 64, Number 193)]
[Notices]               
[Page 54357]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr06oc99-139]                         

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

 
Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated May 12, 1999, and published in the Federal Register 
on may 25, 1999, (64 FR 28214), Research Triangle Institute, Kenneth H. 
Davis, Jr., Hermann Building, East Institute Drive, P.O. Box 12194, 
Research Triangle Park, North Carolina 27709, made application by 
renewal to the Drug Enforcement Administration (DEA) to be registered 
as a bulk manufacturer of the basic classes of controlled substances 
listed below:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)...........................  I
Cocaine (9041).............................  II
------------------------------------------------------------------------

    The institute will manufacture marijuana cigarettes for the 
National Institute on Drug Abuse (NIDA) and the cocaine will be used 
for reference standards, human and animal research, as dictated by 
NIDA.
    No comments or objections have been received. DEA has considered 
the factors in Title 21, United States Code, Section 823(a) and 
determined that the registration of Research Triangle Institute to 
manufacture the listed controlled substances is consistent with the 
public interest at this time. DEA has investigated Research Triangle 
Institute on a regular basis to ensure that the company's continued 
registration is consistent with the public interest. These 
investigations have included inspection and testing of the company's 
physical security systems, audits of the company's records, 
verification of the company's compliance with state and local laws, and 
a review of the company's background and history. Therefore, pursuant 
to 21 U.S.C. 823 and 28 CFR 0.100 and 0.104, the Deputy Assistant 
Administrator, Office of Diversion Control, hereby orders that the 
application submitted by the above firm for registration as a bulk 
manufacturer of the basis classes of controlled substances listed above 
is granted.

    Dated: September 24, 1999.
John H. King,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 99-25904 Filed 10-5-99; 8:45 am]
BILLING CODE 4410-09-M